Keel Point’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-972
Closed -$341K 502
2025
Q4
$341K Buy
972
+88
+10% +$29.7K 0.02% 380
2025
Q3
$286K Sell
884
-605
-41% -$188K 0.02% 421
2025
Q2
$579K Sell
1,489
-14
-0.9% -$5.63K 0.04% 264
2025
Q1
$654K Buy
1,503
+249
+20% +$100K 0.05% 199
2024
Q4
$463K Buy
1,254
+54
+5% +$22.6K 0.04% 253
2024
Q3
$624K Sell
1,200
-43
-3% -$23K 0.05% 201
2024
Q2
$661K Buy
1,243
+86
+7% +$45.5K 0.06% 187
2024
Q1
$600K Buy
1,157
+191
+20% +$95K 0.06% 170
2023
Q4
$456K Buy
966
+34
+4% +$15.7K 0.05% 194
2023
Q3
$406K Buy
932
+86
+10% +$39K 0.06% 189
2023
Q2
$376K Buy
846
+30
+4% +$13.8K 0.05% 207
2023
Q1
$375K Sell
816
-42
-5% -$20K 0.05% 197
2022
Q4
$440K Buy
858
+45
+6% +$22.8K 0.07% 179
2022
Q3
$369K Buy
813
+1
+0.1% +$478 0.06% 170
2022
Q2
$391K Sell
812
-14
-2% -$6.93K 0.06% 173
2022
Q1
$406K Buy
826
+22
+3% +$10.1K 0.06% 174
2021
Q4
$373K Buy
804
+51
+7% +$21.5K 0.04% 184
2021
Q3
$281K Buy
753
+16
+2% +$6.08K 0.04% 203
2021
Q2
$281K Buy
737
+8
+1% +$3.06K 0.03% 208
2021
Q1
$262K Buy
729
+92
+14% +$29.6K 0.03% 220
2020
Q4
$205K Buy
+637
New +$195K 0.02% 234

Other funds holding ELV

Keel Point's ELV Position: Q1 2026 in Review

Keel Point sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 972 shares — an estimated $341K sold.

Keel Point first reported a position in ELV in Q4 2020 and held it in 21 quarters. The position peaked at $661K in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Keel Point reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • Keel Point sold 972 Elevance Health shares in Q1 2026, an estimated $341K.
  • Keel Point first reported a position in Elevance Health in Q4 2020 and held it in 21 quarters.
  • Keel Point's Elevance Health position peaked at $661K in Q2 2024.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Keel Point's 13F filing for Q1 2026, filed 1 Jun 2026.